Author

J. Pietruska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. L. Bayer· 2 shared P. W. Hinds· 2 shared J. Farrell· 1 shared P. Alcaide· 1 shared P. Tsichlis· 1 shared S. K. McRee· 1 shared S. McRee· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. L. Bayer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 24, 2023

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

S. K. McRee, A. L. Bayer, J. Pietruska…·P. W. Hinds

This study shows AKT2 promotes melanoma metastasis while AKT1 is critical for tumor initiation, suggesting AKT2 as a therapeutic target in BRAF-mutant melanoma.

DOI 10.1101/2023.08.24.554685

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivDec 2, 2021

AKT1 is Required for a Complete Palbociclib-induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma

A. L. Bayer, J. Pietruska, J. Farrell…·P. W. Hinds

This study shows AKT1 is required for Palbociclib-induced senescence in BRAF-V600E melanoma cells, acting through NF-kB but not cGAS-STING.

DOI 10.3390/cancers14030572

humanexperimental assay

𝕏 PostBluesky